Gilead Sciences (GILD) Tops Q2 EPS by 41c, Updates Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Needham Starts NeoVolta (NEOV) at Buy
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- KKR launches Helix with over $10 billion to build AI infrastructure
Gilead Sciences (GILD) PT Raised to $81 at Deutsche Bank; Light at the End of the Tunnel
July 27, 2017 8:30 AM EDTDeutsche Bank analyst Andrew Peters raised his price target on Gilead Sciences (NASDAQ: GILD) to $81.00 (from $79.00) while maintaining a Buy rating.
Peters commented, "We are reiterating our Buy rating on GILD and establishing a new $81 price target following a strong beat-and-raise quarter which saw... More
